Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

Osnat Itzhaki Ben Zadok; Ben Ben-Avraham; Anju Nohria; Katia Orvin; Mithal Nassar; Zaza Iakobishvili; Victoria Neiman; Hadar Goldvaser; Ran Kornowski; Tuvia Ben Gal

doi:10.1016/j.jaccao.2019.07.004

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

JACC CardioOncol. 2019 Sep 24;1(1):141-144. doi: 10.1016/j.jaccao.2019.07.004. eCollection 2019 Sep.

Authors

Osnat Itzhaki Ben Zadok^{1

2}, Ben Ben-Avraham^{1

2}, Anju Nohria³, Katia Orvin^{1

2}, Mithal Nassar^{1

2}, Zaza Iakobishvili^{2

4}, Victoria Neiman^{2

5}, Hadar Goldvaser^{2

5}, Ran Kornowski^{1

2}, Tuvia Ben Gal^{1

2}

Affiliations

¹ Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
⁴ Tel-Aviv-Jaffa District, Clalit Health Services, Tel-Aviv, Israel.
⁵ Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.

No abstract available

Keywords: ECG, electrocardiogram; ECMO, extracorporeal membrane oxygenation; ICI, immune-checkpoint inhibitor; LV, left ventricular; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro–B-type natriuretic peptide; TTE, transthoracic echocardiogram; cardiogenic shock; hs-cTnT, high-sensitivity cardiac troponin T; immune-check point inhibitors; myocarditis.

Publication types

Review